Position in BBNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$696,088
-$6,249,730 QoQ
Shares Held
69,470
-69.5% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
5,542,438 | $502,920,823 | |
| 2 | BSX |
Boston Scientific Corp
|
2,414,223 | $103,039,037 | |
| 3 | GKOS |
GLAUKOS Corp
|
314,804 | $43,997,006 | |
| 4 | DXCM |
Dexcom Inc
|
532,804 | $35,884,349 | |
| 5 | EW |
Edwards Lifesciences Corp
|
344,361 | $31,150,895 | |
| 6 | PEN |
Penumbra Inc
|
90,520 | $28,581,689 | |
| 7 | SYK |
Stryker Corp
|
51,116 | $16,093,361 | |
| 8 | GMED |
Globus Medical Inc
|
188,541 | $14,896,623 |
All Filings in BBNX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $696,088 | 69,470 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $6,945,818 | 227,956 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $11,820,702 | 594,902 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $8,953,890 | 614,965 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $8,245,573 | 673,658 | Shares | Other | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||